With renewed research interest in LSD, MDMA, Ketamine, and psilocybin, and a growing normalization after decades of stigma, psychedelics are the next therapeutic frontier. The PsyTech conference was created by the team behind CannaTech, the premier innovation conference for the cannabis industry. Leveraging years of experience building a global cannabis ecosystem, PsyTech is poised to elevate the psychedelics conversation, foster normalization, and accelerate innovation.